Svendsen CN - Search Results

1

Crossroads in GDNF therapy for Parkinson's disease.

Sherer TB, Fiske BK, Svendsen CN, Lang AE, Langston JW. Sherer TB, et al. Among authors: svendsen cn. Mov Disord. 2006 Feb;21(2):136-41. doi: 10.1002/mds.20861. Mov Disord. 2006. PMID: 16470786

2

Stem cells for Parkinson disease and ALS: replacement or protection?

Svendsen CN, Langston JW. Svendsen CN, et al. Nat Med. 2004 Mar;10(3):224-5. doi: 10.1038/nm0304-224. Nat Med. 2004. PMID: 14991036 No abstract available.

3

Stem cells for cell replacement therapy: a therapeutic strategy for HD?

Rosser A, Svendsen CN. Rosser A, et al. Among authors: svendsen cn. Mov Disord. 2014 Sep 15;29(11):1446-54. doi: 10.1002/mds.26026. Mov Disord. 2014. PMID: 25216372 Review.

4

GDNF delivery using human neural progenitor cells in a rat model of ALS.

Klein SM, Behrstock S, McHugh J, Hoffmann K, Wallace K, Suzuki M, Aebischer P, Svendsen CN. Klein SM, et al. Among authors: svendsen cn. Hum Gene Ther. 2005 Apr;16(4):509-21. doi: 10.1089/hum.2005.16.509. Hum Gene Ther. 2005. PMID: 15871682

5

Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF.

Behrstock S, Ebert AD, Klein S, Schmitt M, Moore JM, Svendsen CN. Behrstock S, et al. Among authors: svendsen cn. Cell Transplant. 2008;17(7):753-62. doi: 10.3727/096368908786516819. Cell Transplant. 2008. PMID: 19044202 Free PMC article.

6

Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease.

Ebert AD, Barber AE, Heins BM, Svendsen CN. Ebert AD, et al. Among authors: svendsen cn. Exp Neurol. 2010 Jul;224(1):155-62. doi: 10.1016/j.expneurol.2010.03.005. Epub 2010 Mar 19. Exp Neurol. 2010. PMID: 20227407

7

Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model.

Krakora D, Mulcrone P, Meyer M, Lewis C, Bernau K, Gowing G, Zimprich C, Aebischer P, Svendsen CN, Suzuki M. Krakora D, et al. Among authors: svendsen cn. Mol Ther. 2013 Aug;21(8):1602-10. doi: 10.1038/mt.2013.108. Epub 2013 May 28. Mol Ther. 2013. PMID: 23712039 Free PMC article.

8

GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts.

Sinclair SR, Svendsen CN, Torres EM, Martin D, Fawcett JW, Dunnett SB. Sinclair SR, et al. Among authors: svendsen cn. Neuroreport. 1996 Nov 4;7(15-17):2547-52. doi: 10.1097/00001756-199611040-00029. Neuroreport. 1996. PMID: 8981421

9

Combining growth factors, stem cells, and gene therapy for the aging brain.

Behrstock S, Svendsen CN. Behrstock S, et al. Among authors: svendsen cn. Ann N Y Acad Sci. 2004 Jun;1019:5-14. doi: 10.1196/annals.1297.002. Ann N Y Acad Sci. 2004. PMID: 15246984 Review.

10

Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease.

Ebert AD, Beres AJ, Barber AE, Svendsen CN. Ebert AD, et al. Among authors: svendsen cn. Exp Neurol. 2008 Jan;209(1):213-23. doi: 10.1016/j.expneurol.2007.09.022. Epub 2007 Oct 4. Exp Neurol. 2008. PMID: 18061591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters